Search Results for keywords:"citrate salts"

The Department of Commerce is partially ending its review of the antidumping duty order for citric acid and certain citrate salts from Thailand for the period from July 1, 2019, to June 30, 2020. This decision comes after a timely withdrawal of the request for review by Niran (Thailand) Co., Ltd., with confirmation from U.S. Customs and Border Protection that Niran made no shipments of the merchandise during this period. The review will continue for the other companies, COFCO and Sunshine. Importers are reminded to submit certificates for antidumping duties, and parties need to handle confidential business information according to regulations.

The Department of Commerce has completed an administrative review regarding the sale of citric acid and certain citrate salts by S.A. Citrique Belge N.V. (Citrique Belge) from Belgium during January 8, 2018, to June 30, 2019. They determined that Citrique Belge did not sell these products at prices below the usual market value, resulting in zero antidumping duties. Consequently, the U.S. Customs and Border Protection (CBP) will liquidate relevant entries without imposing additional antidumping duties. The cash deposit requirement for Citrique Belge will be zero, while other manufacturers and exporters not covered by this review will continue with the previous deposit rate until further notice.

The Department of Commerce has determined that two Thai companies, COFCO Biochemical and Niran, sold citric acid and citrate salts in the U.S. at prices below normal value during the specified review period, leading to antidumping duties being assessed on these sales. However, they found that Sunshine Biotech did not sell these products below normal value. The final results of this review mean that these antidumping duties will be applied to affected entries, and specific cash deposit rates are now being implemented for future imports from these firms, except when the margins are minimal. The notice also reminds importers of their responsibilities regarding antidumping duties and the handling of proprietary information.

The U.S. Department of Commerce reviewed the pricing of citric acid and certain citrate salts imported from China by RZBC Group and found that they were not sold in the U.S. at prices below their normal value between May 1, 2022, and April 30, 2023. As a result, no antidumping duties will be imposed on RZBC's exports during this period, and calculations were adjusted following received comments. The finalized results will guide future assessments, and notification to importers regarding antidumping duties is also included in the findings.

The Department of Commerce and the U.S. International Trade Commission have decided to continue the antidumping and countervailing duty orders on citric acid and certain citrate salts from China. This decision is based on findings that removing these orders would likely result in the recurrence of dumping, government subsidies, and harm to the U.S. industry. The continuation of these orders means that additional duties will still be collected on these imports to protect U.S. businesses. This continuation is effective from January 4, 2021, and further reviews will be conducted in the future to assess the situation again.